Cognition disorders in the course of treatment with neuroleptics
Puzyński, S.; Jakubik, A.; Kalinowski, A.
Psychiatria Polska 7(4): 453-459
1973
ISSN/ISBN: 0033-2674 PMID: 4149519 Document Number: 63592
Document emailed within 1 workday
Related Documents
Jarmuzek, Z. 1970: Cognition disorders as a sequel to nialamide treatment Psychiatria Polska 4(2): 157-160Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Neuroleptics and thymoleptics. 3.1 Neuroleptics Fortschritte der Medizin 101(40): 1823; 1826-1827
Adams, A.E. 1971: Physiopathology of cognition disorders Münchener Medizinische Wochenschrift 113(21): 785-792
Otomo, E. 1983: Cognition disorders and dementia in the aged Nihon Rinsho. Japanese Journal of Clinical Medicine 41(10): 2221-2225
Ganner, H.; Kloss, K. 1970: Indication for hospital admission of surgical patients in with cognition disorders Zeitschrift für Allgemeinmedizin 46(29): 1439-1443
Vogt, H.; Bühler, K.E. 1989: Disorders of language and cognition in schizophrenic patients and their effect on communication Zeitschrift für Klinische Psychologie Psychopathologie und Psychotherapie 37(1): 85-95
Kitamura, Y.; Ito, S.; Tezuka, U.; Mori, H.; Nakata, A. 1975: Cognition and speech disorders, right hemiplegia and melena: malignant chorioepithelioma Nihon Rinsho. Japanese Journal of Clinical Medicine Spec No: 822
Odinak, M.M.; Emelin, A.I.; Kovalenko, P.A.; Lobzin, V.I. 2009: Cognition disorders in brain vascular injuries in a military neurologist experience Voenno-Meditsinskii Zhurnal 330(4): 32-40
Etcharry-Bouyx, F.; Gambarelli, D.; Kassis, N.; Gosset, A.; Bonnefoi-Kyriacou, B.; Viallet, F. 1995: Cognition disorders and parkinsonian syndrome: diffuse Lewy body disease? Revue Neurologique (Paris) 151(6-7): 410-412
Jakubowska, T.; Iwińska-Buksowicz, B.; Sobczyk, W.; Luczywek, E. 1992: Early signs of cognition disorders in children with subacute sclerosing panencephalitis in initial stage Neurologia i Neurochirurgia Polska 26(6): 791-798
Ameri, A.A. 2007: Mild cognition disorders signal increased risk of dementia. How can mental decline be stopped? MMW Fortschritte der Medizin 149(33-34): 14
Andersson, J.C.; Morel, P.; Poilpre, E.; Baron, J.B. 1977: Statokinesimetric and clinical study of extrapyramidal disorders induced by neuroleptics in a population of mental patients Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 18(Special Issue): 35-43
Geronimi-Ferret, D.; Lesay, M.; Barges-Bertocchio, M.H.; Cornet-Bonnefont, M.; Robert, H. 1997: Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics L'Encephale 23(Special Issue 4): 24-31
Guensberger, E.; Molcan, J. 1978: The aim of neuroleptics in the context of the treatment of depression Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 19(C): 121-124
Zaitsev, V.P. 1975: Differentiated use of neuroleptics in treatment of myocardial infarct Klinicheskaia Meditsina 53(7): 61-65
Marsálek, M. 1989: Tardive dyskinesia after low doses of neuroleptics and attempts at treatment Ceskoslovenska Psychiatrie 85(2): 100-105
Rust, M. 1983: Use of tiapride in persistent tardive dyskinesia following treatment with neuroleptics Münchener Medizinische Wochenschrift 125(21): 461-462
Waehrens, J. 1982: Convulsions during simultaneous treatment with neuroleptics and antidepressive agents Ugeskrift for Laeger 144(2): 106-108
Paolucci, S.; Buttinelli, C.; Fiume, S.; Ciani, S.; Lenzi, G.L. 1984: Treatment of Gilles de la Tourette syndrome with depot neuroleptics Acta Neurologica 6(3): 222-224
Masi, G. 1997: Atypical neuroleptics in the treatment of early onset schizophrenia Panminerva Medica 39(3): 215-221